Pages without language links

From IDWiki

The following pages do not link to other language versions.

Showing below up to 500 results in range #51 to #550.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Acute kidney injury in pregnancy
  2. Acute kidney injury in renal transplant
  3. Acute loss of consciousness
  4. Acute mountain sickness
  5. Acute myeloid leukemia
  6. Acute necrotizing encephalopathy
  7. Acute promyelocytic leukemia
  8. Acute respiratory distress syndrome
  9. Acute retinal necrosis
  10. Acute rheumatic fever
  11. Acute severe headache
  12. Acute spinal cord compression
  13. Acute stroke
  14. Acute toxic leukoencephalopathy
  15. Acute triglyceridemic pancreatitis
  16. Acute urinary retention
  17. Acyclovir
  18. Adalimumab
  19. Adenovirus
  20. Adrenal insufficiency
  21. Adult-onset Still's disease
  22. Adverse drug reaction
  23. Adverse event
  24. Aerococcus
  25. Aerococcus sanguinicola
  26. Aeromonas
  27. Aflatoxin
  28. Aggregatibacter
  29. Agranulocytosis
  30. Agrobacterium
  31. Albendazole
  32. Alcaligenes
  33. Alcaligenes faecalis
  34. Alcohol, smoking and substance involvement screening test
  35. Alcohol in the elderly
  36. Alcohol use disorder
  37. Alcohol withdrawal
  38. Alcoholic hepatitis
  39. Alefacept
  40. Alemtuzumab
  41. Alkaline phosphatase
  42. Allergic bronchopulmonary aspergillosis
  43. Alpha-fetoprotein
  44. Alpha-gal syndrome
  45. Altered mental status
  46. Alternaria
  47. Alzheimer's communication strategies
  48. Alzheimer disease
  49. Amblyomma americanum
  50. Amblyomma maculatum
  51. Ambulatory blood pressure monitor
  52. Amikacin
  53. Aminoglycosides
  54. Amoxicillin-clavulanic acid
  55. AmpC β-lactamase
  56. Amphotericin B
  57. Ampicillin-sulbactam
  58. Amyloidosis
  59. Amyotrophic lateral sclerosis
  60. Anaerobiospirillum succiniciproducens
  61. Anakinra
  62. Anaphylaxis
  63. Anaplasma phagocytophilum
  64. Anemia
  65. Angioimmunoblastic T-cell lymphoma
  66. Angiostrongylus cantonensis
  67. Animal bite
  68. Anion gap metabolic acidosis
  69. Anisakidosis
  70. Anisocoria
  71. Ankylosing spondylitis
  72. Anti-nuclear antibody
  73. Antibiograms
  74. Antibiotic-associated diarrhea
  75. Antibiotic prophylaxis for open fractures
  76. Antibiotic prophylaxis for procedures
  77. Antibiotic spectrum index
  78. Antibiotics in sodium restriction
  79. Anticoagulation
  80. Antiepileptic drugs
  81. Antifungal spectrum of activity
  82. Antifungals
  83. Antimicrobial abbreviations
  84. Antimicrobial stewardship program
  85. Antimicrobials in breastfeeding
  86. Antimicrobials in pregnancy
  87. Antineutrophil cytoplasmic antibody
  88. Antipseudomonal antibiotics
  89. Antiretroviral resistance in HIV
  90. Antistreptolysin O
  91. Antiviral resistance in CMV
  92. Antiviral spectrum of activity
  93. Aortic graft infection
  94. Aortic root abscess
  95. Aortic stenosis
  96. Aortitis
  97. Aphasia
  98. Aplastic anemia
  99. Apophysomyces elegans
  100. Approach to Clinical Syndromes: Part I
  101. Arboviruses
  102. Arcanobacterium haemolyticum
  103. Artesunate
  104. Arthrocentesis of the knee
  105. Arthropods
  106. Ascaris lumbricoides
  107. Ascites
  108. Aseptic meningitis
  109. Aseptic meningitis with genital lesions
  110. Aspergillus
  111. Aspergillus oryzae
  112. Aspergillus sojae
  113. Asplenia and hyposplenia
  114. Asthma
  115. Asthma-COPD overlap syndrome
  116. Asthma in pregnancy
  117. Asymptomatic bacteriuria
  118. Asymptomatic bacteriuria in pregnancy
  119. Atopobium rimae
  120. Atovaquone
  121. Atovaquone-proguanil
  122. Atrial fibrillation
  123. Atypical femoral fracture
  124. Atypical hemolytic-uremic syndrome
  125. Atypical lymphocytosis
  126. Atypical pneumonia
  127. Aureobasidium
  128. Aureobasidium pullulans
  129. Auricular chondritis
  130. Autism spectrum disorder
  131. Autoimmune hemolytic anemia
  132. Autoimmune hepatitis
  133. Autoimmune pancreatitis
  134. Autoimmune polyendocrinopathy, candidiasis, and ectodermal dystrophy
  135. Autosomal dominant polycystic kidney disease
  136. Avian paramyxovirus type 1
  137. Azacitidine
  138. BASCULE syndrome
  139. BK virus
  140. Babesia microti
  141. Bacillary angiomatosis
  142. Bacillus
  143. Bacillus anthracis
  144. Bacillus cereus
  145. Bacteremia
  146. Bacteria
  147. Bacterial meningitis
  148. Bacterial meningitis (IDSA 2004)
  149. Bacterial vaginosis
  150. Bacteroides fragilis group
  151. Balamuthia mandrillaris
  152. Balantidium coli
  153. Baltimore classification of viruses
  154. Baricitinib
  155. Bartonella
  156. Bartonella bacilliformis
  157. Bartonella henselae
  158. Bartonella quintana
  159. Basidiobolus ranarum
  160. Basophilic stippling
  161. Baylisascaris procyonis
  162. Bedaquiline
  163. Behçet disease
  164. Behçet disease
  165. Being a Consultant
  166. Bell palsy
  167. Benign prostatic hypertrophy
  168. Benzodiazepine use disorder
  169. Benzodiazepines
  170. Bevacizumab
  171. Biapical scarring
  172. Bile esculin agar
  173. Bilirubin
  174. Biofilm
  175. Biophysical profile
  176. Biosafety risk groups
  177. Bioterrorism agents
  178. Bispecific T-cell engager
  179. Black yeasts
  180. Bladder pain syndrome
  181. Blastocystis hominis
  182. Blastomyces dermatitidis
  183. Blood-borne infections
  184. Blood culture
  185. Blood culture contamination
  186. Blood transfusion
  187. Blue-green algae
  188. Blue sclerae
  189. Body surface area
  190. Bone marrow biopsy
  191. Bony metastases
  192. Bordetella
  193. Bordetella pertussis
  194. Borrelia
  195. Borrelia burgdorferi
  196. Borrelia hermsii
  197. Borrelia mayonii
  198. Borrelia miyamotoi
  199. Borrelia parkeri
  200. Borrelia recurrentis
  201. Borrelia turicatae
  202. Bortezomib
  203. Botryomycosis
  204. Boutonniere deformity
  205. Brachial plexus syndrome
  206. Bradycardia
  207. Brain abscess
  208. Brain death
  209. Brentuximab vedotin
  210. Brevibacillus
  211. Brevundimonas
  212. Brincidofovir
  213. Brodie abscess
  214. Bronchiectasis
  215. Brucella
  216. Brucella melitensis
  217. Brugada syndrome
  218. Bunyavirales
  219. Buprenorphine
  220. Burkholderia
  221. Burkholderia cepacia complex
  222. Burkholderia mallei
  223. Burkholderia pseudomallei
  224. Burning mouth syndrome
  225. Bursitis
  226. C-reactive protein
  227. CAPS
  228. CCU drugs and concentrations
  229. CD markers
  230. CHEAP TORCHES
  231. CMV after hematopoietic stem cell transplantation
  232. CMV after solid organ transplantation
  233. CMV in HIV patients
  234. CMV in pregnancy
  235. CMV retinitis in HIV patients
  236. CNS calcifications in neonates
  237. CNS infections in HIV patients
  238. COVID-19-associated pulmonary aspergillosis
  239. CR:DOI:00acfd050b7608cdad2cda8ddc922cbf
  240. CR:DOI:0169c23afd306a21ede91427ae6dc828
  241. CR:DOI:02ebac30bd4090e729efc4a882b6c93d
  242. CR:DOI:0829a713e95cbbd4b450ed29b107c622
  243. CR:DOI:09649f204e0f789481cbf2b6e9852750
  244. CR:DOI:098bf7f228d86a0a7768623ab8017fde
  245. CR:DOI:0b4b004dd3ae98c4f75ebf3cff47e3ab
  246. CR:DOI:0b4d5fbdb5a3461e1d4ad9a0bd9c7b57
  247. CR:DOI:0bbf52c7a66f6ed4bdd0dbd95b094a7d
  248. CR:DOI:0bf8ee2ef119a747eb1ef476f7e7b719
  249. CR:DOI:0d1e5dc1202ab7a7a86f7e814306e82e
  250. CR:DOI:0f2325db60edc6b9b12ea02b0aa425e2
  251. CR:DOI:13494e2091d6ab067b36b569529e4e8c
  252. CR:DOI:143a8a4e98ce78f59bd9439c01575f67
  253. CR:DOI:14d8f96aed7b8566166d94219db9c587
  254. CR:DOI:1591ed0715e4656cc34c6ad134c82fbd
  255. CR:DOI:176b5770c3f3682ece04fcb9d7722a0c
  256. CR:DOI:18cf3d3fef3630ee3cbf73381ad15ac6
  257. CR:DOI:195968321ee211df1e7dbd126a34f592
  258. CR:DOI:19d44b0938e9b8f10c901d23de6156fb
  259. CR:DOI:1c13eb71190fd747a0ca4de5035dcf0d
  260. CR:DOI:1da74b622a953e9ec15f52a5d9406f23
  261. CR:DOI:1e05c9fa81f92bdccea40e74e189de3b
  262. CR:DOI:1e0f196e8979f77a82c63ac7c9a6256a
  263. CR:DOI:1e310ed8dee76dde0ef65abfc6ac6418
  264. CR:DOI:2030b67e3e5ece9bb99885a6c6b65add
  265. CR:DOI:20b1483903240f2c41f322f3dd0c9300
  266. CR:DOI:223da6637bb9228360819cb97fb77f2f
  267. CR:DOI:234faee71b76a3460d05a93808ef21c7
  268. CR:DOI:2367c9a916ae67d97ccfd3dd0a19f3b6
  269. CR:DOI:23eb96f7b0f18d6fd85814605a856558
  270. CR:DOI:255d85f5162682b856cfd0b102c7d93d
  271. CR:DOI:27d9c2886cfe6db6618a894fb602548c
  272. CR:DOI:293185aec9b19fa57075d19dae14d2f3
  273. CR:DOI:2c6a5b651fff9c9cbd6341dfbc9a5a36
  274. CR:DOI:2ca01566cd9046e6582daa1bf4f11b9c
  275. CR:DOI:2d3c452047be5089ceb85dbafbd2293f
  276. CR:DOI:2e0ee443bdb0d5c5c74ff7f8f34ad6e3
  277. CR:DOI:2e985fec4cbd3c0bbd083450d443effc
  278. CR:DOI:2f556ae27a0ead10bdc78afc7d591782
  279. CR:DOI:2f593bbb879ddf6273cb080b1f82f881
  280. CR:DOI:313b2c31a000cc7719c112463f068c86
  281. CR:DOI:31924dec18fa6f8a5f9c873f28f52af4
  282. CR:DOI:3220ecfd9746207590bda96a386c4a36
  283. CR:DOI:324eb4fd5a300cb39055ab08c9026796
  284. CR:DOI:351be4f8e400189bf2f9e9883575b08a
  285. CR:DOI:35deea6bca62469c53a8d1db72080a12
  286. CR:DOI:36b2aaede1423d248c277a1d68a528ac
  287. CR:DOI:371c72784a9d025db2bbe9b0f9c987a2
  288. CR:DOI:381b8d6868d4be132eeedf751c3edd0d
  289. CR:DOI:382cbd759b8401371e6f1c4551d1b3ef
  290. CR:DOI:38bbaf88b704c9b50a847fff5a13ee30
  291. CR:DOI:3c928b7df7a9405c7077dbadb984160c
  292. CR:DOI:3e6405399d321f945f2db0124b2e277f
  293. CR:DOI:3f57dcdfc0c902341df2343eaa856e3c
  294. CR:DOI:41b8b943fd352e7db17fae6598a2efc5
  295. CR:DOI:42c3d87de298a0073c36a9b9299751ff
  296. CR:DOI:45fdd9d93c8d6c80b99b6f38d0dccd38
  297. CR:DOI:46123634f2a85fd729368e2defc622c3
  298. CR:DOI:48b240d4a5da84271e0e30de474dcd52
  299. CR:DOI:48b3c3d59b243389e5f28b00d4db15f7
  300. CR:DOI:49aed2104d605ef8c28d5a0086f55319
  301. CR:DOI:4b5520861f644af6fc2c40ee3cd59320
  302. CR:DOI:4c59f810dcfde02ea4b210db2513a067
  303. CR:DOI:4c62a9e4b664859cb8d5027e0d0cbcad
  304. CR:DOI:4d444b3e3d1c4b2a93077fef5f98dde1
  305. CR:DOI:4dc6ace4215c8fc18ce986fa74da8519
  306. CR:DOI:4eb9cd71fdb59132cfc7c3dba7ad9fb4
  307. CR:DOI:4f2e8e91c22157d3b7c76e51388fa695
  308. CR:DOI:4f998a83c8e5f34dd6c814a6b14ebcfc
  309. CR:DOI:50980a9543271b913bd7bc6b0e2bc449
  310. CR:DOI:510aa6dad1509646765db21a07cc0c5a
  311. CR:DOI:51fa8f54739ab5a0e6de54d5a40a6926
  312. CR:DOI:533fdca5d7624a0a92c34442ff9c6b94
  313. CR:DOI:54261e0f60b000f250d27de501384afa
  314. CR:DOI:557ada687368f8167ededa806f865c2e
  315. CR:DOI:55f07f8124c04d4c31455e83a0c55748
  316. CR:DOI:56b67522689053f83c75be4984e0ef3a
  317. CR:DOI:56f88ff55f20b5c9e5c5a475f2466bad
  318. CR:DOI:57b132d01e0b0b10e5ff13b429bedb3c
  319. CR:DOI:5833dec2f6a1c81a835d3b7ec30850b1
  320. CR:DOI:58518b26913a03a3a4637e6abef3fb42
  321. CR:DOI:58a5342a18d98576e4a3479ebd6e5cf4
  322. CR:DOI:597122a60ca1220bc34eb933860bd38f
  323. CR:DOI:5f48b1fa391b1e412ae002eff571f917
  324. CR:DOI:60c42ee946fc6f8b9ba4d0e3baaaf7f4
  325. CR:DOI:613c770c895ebbe5fc01a70fe1b3c416
  326. CR:DOI:6146a23d59736fcd2b396575d91711ab
  327. CR:DOI:614fcb9a3c158a27860e0102cdd1dcf2
  328. CR:DOI:62ad3dd3dc742a32dd360c00b0f1fa4e
  329. CR:DOI:644b0ce19e450a09f9761d4c0febe015
  330. CR:DOI:66d3dbdffc22787fa9886b680bcbe5af
  331. CR:DOI:69046e808a898fdd77c4ac32e439e6b4
  332. CR:DOI:6920036664d2ce14878b939de0c03bee
  333. CR:DOI:6b3504fe47b788cd73d9f53626512a76
  334. CR:DOI:6cc99a5f77a6e9655d861ca2d1fc3c25
  335. CR:DOI:6cf032b3d733b8eafe7627257ce067d8
  336. CR:DOI:70c34359173ec1e91957314a02fc912c
  337. CR:DOI:7254dfd1e81a7ea8486654594db40a33
  338. CR:DOI:73b23397ddf1b35e6e13135126af8592
  339. CR:DOI:73b2cdb289567bf944b834884b982b23
  340. CR:DOI:7604bb4eccd4b0f35ba1fdcbedc183d2
  341. CR:DOI:76eef683079d96f46f56a6eccb733f17
  342. CR:DOI:77147f64e95d0ee78ea5ca66fa95c6e8
  343. CR:DOI:7969fde7934d219f61cfb5b37b270589
  344. CR:DOI:7988f4e33cb568e454f460cedbaa2940
  345. CR:DOI:7a71a1068c5ec01ab6e0764dcec5f8c2
  346. CR:DOI:7aec6782ab7f966603cc1751d65939c6
  347. CR:DOI:7b64fbf5d1021ab5bc68e15d258d1c25
  348. CR:DOI:7d2e2c64e14fe7c2a7ddfcb7017ccd67
  349. CR:DOI:7d6ce2d7fae52c13a3710fe89fc1d156
  350. CR:DOI:7f975170e17677f247daf22ae675d056
  351. CR:DOI:80ac657299c1a711fa7215edaa1fadcc
  352. CR:DOI:826f44adf4ce8ff6d4aa09a3564d0b24
  353. CR:DOI:830c5487c774f8a7a48f8f9e0c62029d
  354. CR:DOI:8364a8096db2e5fc7ac5fc7a06486748
  355. CR:DOI:8506cec6b1b04a68e434f042f7970dee
  356. CR:DOI:850ebb9e55e1f8cb092dddb52604c3ad
  357. CR:DOI:85b8b38f010838c55c8dd50923ee4b2b
  358. CR:DOI:893409d5f0d7ba865248047593988ab6
  359. CR:DOI:8a714e7544931f5a7aaaa026eb94bbaf
  360. CR:DOI:8cf276af02c1dee0d890220e9c4da472
  361. CR:DOI:8e2bad092ff079112b6816a5cc9f7230
  362. CR:DOI:8f3240a268c2269cf5f9bd1919a1db73
  363. CR:DOI:9001a5594f91dd6bf04eed25ac6ece98
  364. CR:DOI:90ca6feed9950cd48c5b12b7b7550739
  365. CR:DOI:926849ee14178552466c9adb43cafb90
  366. CR:DOI:92b0de46627d5069ae83b2a958b3cade
  367. CR:DOI:9333507aa0777a2dcb0ad6ece486f2c4
  368. CR:DOI:96250abe143582f71379fd5cc5a967ba
  369. CR:DOI:991f964bc1636d5dc191102bc25371bc
  370. CR:DOI:99200ff9965ceb04ad4d994ff98238f9
  371. CR:DOI:9a9d6cf3877fa597720e8174af13e90a
  372. CR:DOI:9a9e7f94d3dbf38ac747d552bbdff29e
  373. CR:DOI:9b9f4703054d4d499267c45c830f0f17
  374. CR:DOI:9d273044ed65d2e7fdb137fd33f1463b
  375. CR:DOI:9d68353d98e4176c52cd7ca96bd0a5ee
  376. CR:DOI:9e3503306da31f0700db99291beb5a46
  377. CR:DOI:9e91b940cf2d14742e8ff93036e10367
  378. CR:DOI:9ea1fcc42d82a8f13d9195b4bac5089f
  379. CR:DOI:9f701ec0217fe70d85c3837300571e40
  380. CR:DOI:a03981074b893893d5c9079ba13a439a
  381. CR:DOI:a42a65d4fb68f23b919fc8e857254388
  382. CR:DOI:a5039d8fa9a9e85d7e59d1cc57b33c8d
  383. CR:DOI:a55f83309a6e6f4ddbc632334a718bda
  384. CR:DOI:a6cfc8365ba65418d8e874a9af6bf662
  385. CR:DOI:aa6bb58cbee93a153689ff84b3815be0
  386. CR:DOI:ac2ff4083d127703e7482aa3c074fb69
  387. CR:DOI:afa00911a5a2cec5c1481f40f6a2acaa
  388. CR:DOI:afb3d02bc01ad3adc6010f37c10a92c3
  389. CR:DOI:afdbe434d5ad2e5e08c8e31bcdd84a86
  390. CR:DOI:b017ffb414d9bb215a114e2ea2875ca8
  391. CR:DOI:b18951172a5ba4e6e6fb8038c0ef1eb3
  392. CR:DOI:b2fbffadb731b73f5d5ca77aa60b3402
  393. CR:DOI:b4c581c4c9d64c391ae075e32142b7d3
  394. CR:DOI:b5eea92fc03256e3a3891b33ea68ee03
  395. CR:DOI:b694f1fe4184f2013ae0f676769dfddb
  396. CR:DOI:b6d1517c4f96004781d4914b8f63b6cc
  397. CR:DOI:b9317030589eded6198a6dff29ba59a1
  398. CR:DOI:bae7ec07e96a98c3bcc5253cf11d51a4
  399. CR:DOI:bc540372b9861b01e05bd4aaea395e0c
  400. CR:DOI:bc7f64d0251e73e5b7f31169b9aa0e5c
  401. CR:DOI:bd2ea72744822eef2e3068efbc1f6487
  402. CR:DOI:bea29a18d527d7c8aa1be9ec4df73f28
  403. CR:DOI:c0b6fccc2bce1614316f03e181e9ac45
  404. CR:DOI:c42f8e714142c02d04f01aefa1424fe5
  405. CR:DOI:c5086c57c4ad4641b7ee0e15b2ed35a2
  406. CR:DOI:c582662a81555a86aff0b8a29eeec24a
  407. CR:DOI:c5c6b676bc94c7d0bd1a1cd08c63b49b
  408. CR:DOI:c605aab953141c2376f3b8840f0d6d24
  409. CR:DOI:c6b0b2592ddf24cc5b656bbc4bbc13b2
  410. CR:DOI:c6f06e5cb3f5f8125ec5044919cba493
  411. CR:DOI:c7ae99a571f3ad477b69e76c8c773cf1
  412. CR:DOI:c91bcc94c1cca91ebafc0d98e0111e36
  413. CR:DOI:c961643b98eb32b71d42061b4a690ff2
  414. CR:DOI:ccd5d5c1dccfdd0379d60fc4914b9cc9
  415. CR:DOI:cdd117fd2789acc892d8beba9a9eca85
  416. CR:DOI:ce6f57a7754af2e2b88d4a54e9502aa3
  417. CR:DOI:ceeb91106002ee6438eacfb26f0b10a7
  418. CR:DOI:cf12a2e71e10680224350782afca9229
  419. CR:DOI:cfa2f2c6cc6af3632365c3ef86e7b61b
  420. CR:DOI:d059f5c267865beaebd7cd623ece4200
  421. CR:DOI:d0a6ae27f8da47002a176a60aae6a653
  422. CR:DOI:d0cf721f1b11c4947d9d584119e157fa
  423. CR:DOI:d236bdb9afe11cd60f12e3273f0048b2
  424. CR:DOI:d2884a88cacf48ac2b493190c74095af
  425. CR:DOI:d3bebd2106abfdceaa1e3492cd96f23d
  426. CR:DOI:d41a8ec870b77924908b44793d923353
  427. CR:DOI:d5c04bb4b0770dd9f52f5047e0a08bd3
  428. CR:DOI:d5cfc4aad6ac951a2c7a8958a321b5f0
  429. CR:DOI:d5db41d23de6623c6d13b0ffe1bc808b
  430. CR:DOI:d68983ed726f4d84bcc8a9342993d266
  431. CR:DOI:d6b3e528c1da9aa7d85a80ece2de9c49
  432. CR:DOI:d79ef6403423785d7445a287d9f5298f
  433. CR:DOI:d7e82ec5e5ad23fe3de0c2225396c4f1
  434. CR:DOI:d82d682cf09ec9411ac3793a322c1d58
  435. CR:DOI:d9fde7c28126ef69c9bed6360f3faa3c
  436. CR:DOI:dafc088b4572e68608d6120f4657c7f1
  437. CR:DOI:dbb615d69b352690f9b5e72343bb77ae
  438. CR:DOI:dfdd401efc8af1bb57368e5d50e31249
  439. CR:DOI:e27c5a4887971b847d54ab78959726af
  440. CR:DOI:e4b88dce4876a095de40d59ac19b0407
  441. CR:DOI:e685b2d71da14c2ca90bb1aeff3daa02
  442. CR:DOI:e76fc2def278ad7232367b9a92790427
  443. CR:DOI:e7d5997f6ba302aad44373195ab7f4fa
  444. CR:DOI:e940663c9b21ee851fa892d61de390ea
  445. CR:DOI:e988b075cb077114b3f7be1c30a2e105
  446. CR:DOI:ed606f5d19db857530752a358b3e0da4
  447. CR:DOI:ee68d2935f07f1456c07b4a6efab4f88
  448. CR:DOI:ee817dfd46decead39dbf489a2269574
  449. CR:DOI:eedd582daf4760b5c5c9016cfb9ce141
  450. CR:DOI:ef785e49306653503e384afbd5301d94
  451. CR:DOI:efdffe9dd629e8fd9c8ecd6ea8c67d85
  452. CR:DOI:f02e515a07b7b94afb259db5668e8149
  453. CR:DOI:f2bc8ca361433624910e9509a2858ea4
  454. CR:DOI:f3a34c3cfd0c645bb74d5a5110a3c1db
  455. CR:DOI:f4577849ce48a1dcf269d14f81fe5c63
  456. CR:DOI:f4828257713983f4f218bf13c82aa992
  457. CR:DOI:f4aad4874d2af27c38068e31536883a4
  458. CR:DOI:f4e55de3e93e1cc0791c0ecc51200841
  459. CR:DOI:f4f4f2345f21b543768964b5b3a01098
  460. CR:DOI:f51db4ec8feb93e7b529fcc6f333f7ea
  461. CR:DOI:fa5a924ce400bc9f7a71b219c95b68c2
  462. CR:DOI:fa5d39fcf5033e393d73c851728bc1c4
  463. CR:DOI:fbacb1b82c9cb607c04d96825dc511c9
  464. CR:DOI:fc0cca0430a2a28873d307c01af2f44f
  465. CR:DOI:ffad72a5ea00cd8bc8c4056a9c99d4a0
  466. CR:OCLC:978699031
  467. CR:PMID:10221307
  468. CR:PMID:1758788
  469. CR:PMID:18785780
  470. CR:PMID:32040709
  471. CR:PMID:3867865
  472. CSF pleocytosis
  473. CT contrast reactions
  474. Cabot ring
  475. Cabotegravir/rilpivirine
  476. Café-au-lait spots
  477. Calciphylaxis
  478. Calcium channel blocker toxicity
  479. Calcium pyrophosphate crystal deposition
  480. Caliciviridae
  481. California encephalitis virus
  482. Calvaria
  483. Calvarial lesion
  484. Campylobacter
  485. Campylobacter coli
  486. Campylobacter jejuni
  487. Campylobacter ureolyticus
  488. Canadian Transient Ischemic Attack Score
  489. Cancer of unknown primary
  490. Candida
  491. Cannabis use disorder
  492. Capillary refill time
  493. Capnocytophaga
  494. Capnocytophaga canimorsus
  495. Capsular warning syndrome
  496. Carbapenem-resistant organisms
  497. Carbapenemase-producing Enterobacteriaceae
  498. Carbapenemases
  499. Carbon monoxide toxicity
  500. Carcinoid syndrome

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://idwiki.org/Special:WithoutInterwiki"
Powered by MediaWiki
Powered by Semantic MediaWiki